PCDH17 and esophageal cancer: Notably, the putative methylation driver PCDH17 was previously described as a tumor suppressor that induces tumor cell apoptosis and autophagy, and was functionally hypermethylated in gastric, colorectal, urological and esophageal cancers 76-78.